Christine Min, MD
Radiation Oncology · Hiram, GANPI 1609039882
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $545 and has fallen 72.4% since, to $150 in 2025.
Across 53 payments — averaging $25.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$200
- Progenics Pharmaceuticals, Inc.$188
- Siemens Medical Solutions USA, Inc.$180
- Reflexion Medical, Inc.$175
- E.r. Squibb & Sons, L.L.C.$120
- Novartis$94
- plus $396 from 13 others
What the payments were for
- Food & beverage$1,353100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 5 | $200 |
| Progenics Pharmaceuticals, Inc. | 2 | $188 |
| Siemens Medical Solutions USA, Inc. | 4 | $180 |
| Reflexion Medical, Inc. | 7 | $175 |
| E.r. Squibb & Sons, L.L.C. | 7 | $120 |
| Novartis | 4 | $94 |
| Seagen Inc. | 5 | $83 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $47 |
| Tesaro, Inc. | 2 | $41 |
| Fortovia Therapeutics, Inc. | 2 | $40 |
| Merck | 2 | $31 |
| Novocure Inc. | 2 | $29 |
| Bayer | 1 | $25 |
| Angiodynamics, Inc. | 1 | $22 |
| Clovis Oncology, Inc. | 2 | $22 |
| Boehringer Ingelheim | 1 | $19 |
| Eisai Inc. | 1 | $14 |
| Pfizer | 1 | $12 |
| AbbVie | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,353 in reported general payments places this provider in the 75th percentile of 165 radiation oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Hiram
- Adam FerroHiram$5K
- Rakendu ShuklaHiram$929
- Kristin HigginsAtlanta$230K
- Walter CurranAtlanta$83K
- Ian CrockerAtlanta$51K
- Sagar PatelAtlanta$32K
- Hui-Kuo ShuAtlanta$25K
- Wilfred WilliamsAtlanta$15K
- Nancy WiggersAtlanta$11K
- Adam NowlanAtlanta$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.